Literature DB >> 36032919

Outcome of Canal Wall Down Mastoidectomy: A Retrospective Review.

Mohit Samadhiya1, Harsh Agarwal1, Sudhakar Vaidya1, J K Sharma1.   

Abstract

A canal wall down mastoidectomy (CWDM) is an effective technique for eradication of chronic suppurative otitis media (atticoantral disease) or cholesteatomas. A retrospective study was conducted at R.D. Gardi Medical college between 2015 and 2017 to evaluate the outcome of CWDM for patients with atticoantral type of CSOM. All new cases of MRM/RM which fulfilled the selection criteria were reviewed. The main outcome measures were the hearing outcome and status of dry ear postoperatively. 60 patients of CWDM (32 male, 28 female) were included for analysis. All patients in our study were between 7 and 52 years with mean age 28.38 years. The ossicular chain was eroded in all the cases. Improvement in Air-Bone-Gap was seen in 11 (18.33%), no change in 38 (63.33%) and 11 (18.33%) had deteriorated. In post operative outcome study of our 60 patients, 76.66% of the patients had dry healed cavity and non healed cavity was found to be in 23.33% of the patients. On analysis of data and comparison with other studies it was found that there are three important factors which influence hearing results and the outcome of surgery-status of ossicular chain, presence or absence of cholesteatoma, recurrence or residual disease. © Association of Otolaryngologists of India 2020.

Entities:  

Keywords:  CSOM; Canal wall down mastoidectomy; Cholesteatoma; Modified radical mastoidectomy; Tympanoplasty

Year:  2020        PMID: 36032919      PMCID: PMC9411466          DOI: 10.1007/s12070-019-01778-9

Source DB:  PubMed          Journal:  Indian J Otolaryngol Head Neck Surg        ISSN: 2231-3796


  17 in total

1.  The behavior of mastoidectomy cavities following modified radical mastoidectomy.

Authors:  Gundula Thiel; John A Rutka; David D Pothier
Journal:  Laryngoscope       Date:  2014-07-14       Impact factor: 3.325

2.  Hearing results following modified radical versus canal-up mastoidectomy.

Authors:  J A Cook; S Krishnan; P A Fagan
Journal:  Ann Otol Rhinol Laryngol       Date:  1996-05       Impact factor: 1.547

3.  Canal wall down mastoidectomy: causes of failure, pitfalls and their management.

Authors:  S Bhatia; S Karmarkar; G DeDonato; C Mutlu; A Taibah; A Russo; M Sanna
Journal:  J Laryngol Otol       Date:  1995-07       Impact factor: 1.469

4.  Extensive cholesteatoma: long-term results of three surgical techniques.

Authors:  M Nyrop; P Bonding
Journal:  J Laryngol Otol       Date:  1997-06       Impact factor: 1.469

5.  The diagnostic accuracy of non-echo-planar diffusion-weighted imaging in the detection of residual and/or recurrent cholesteatoma of the temporal bone.

Authors:  M H G Dremmen; P A M Hofman; J R Hof; R J Stokroos; A A Postma
Journal:  AJNR Am J Neuroradiol       Date:  2011-12-22       Impact factor: 3.825

6.  The use of Davis pinch grafts to promote epithelialization in a post- mastoidectomy cavity.

Authors:  D A Bowdler; R M Walsh
Journal:  Rev Laryngol Otol Rhinol (Bord)       Date:  1995

7.  Value of echo-planar diffusion-weighted MRI in the detection of secondary and postoperative relapsing/residual cholesteatoma.

Authors:  Alessandro Stasolla; Giuseppe Magliulo; Luigi Lo Mele; Giancarlo Prossomariti; Giacomo Luppi; Mario Marini
Journal:  Radiol Med       Date:  2004 May-Jun       Impact factor: 3.469

8.  Intact canal wall tympanoplasty with mastoidectomy for cholesteatoma: long-term follow-up.

Authors:  S E Kinney
Journal:  Laryngoscope       Date:  1988-11       Impact factor: 3.325

9.  The value of diffusion-weighted MR imaging in the diagnosis of primary acquired and residual cholesteatoma: a surgical verified study of 100 patients.

Authors:  Jean-Philippe Vercruysse; Bert De Foer; Marc Pouillon; Thomas Somers; Jan Casselman; Erwin Offeciers
Journal:  Eur Radiol       Date:  2006-03-03       Impact factor: 5.315

10.  Epithelial migration in open mastoidectomy cavities.

Authors:  R Youngs
Journal:  J Laryngol Otol       Date:  1995-04       Impact factor: 1.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.